Insulet | PODD - Ebitda



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 480.4M
销售成本
USD 232.7M
流动资产
USD 1.71B
流动负债
USD 687.5M
债务
USD 949.2M
EBIT
USD 122M
EBITDA
USD 181.7M
员工
3.9K
EPS每股收益
USD 1.42
股本和储备
USD 1.3B
销售毛利
USD 540.8M
债务利息支出
USD 14.7M
利息收入
USD 5.7M
贷款资金
USD 929.5M
市值
USD 9.97B
净收入
USD 91.1M
营业费用
USD 639.7M
营业利润
USD 122M
普通股股本
USD 69.26M
PE价格收益
38.83
税前利润
USD 113M
销售收入
USD 761.7M
销售和管理费用
USD 317.2M
股票
USD 462.5M
贸易债权人
USD 149.8M
应收帐款人
USD 544.7M


Ebitda 更改 日
Abbott USD 3.27B 178M 2025-12
Align Technology USD 260.87M 77.03M 2025-12
AtriCure USD 17.07M 2.79M 2026-03
Avanos Medical USD 13M 3M 2025-12
Baxter International USD -447M 873M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.16B 213M 2025-12
Cardinal Health USD 1.09B 109M 2026-03
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 364.5M 57.7M 2026-03
Edwards Lifesciences USD 70.1M 394.2M 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
Globus Medical USD 280.46M 27.86M 2025-12
ICU Medical USD 98.68M 489K 2026-03
Insulet USD 181.7M 12.3M 2026-03
Integra LifeSciences USD 76.18M 28.03M 2026-03
J&J USD 7.19B 2.32B 2025-12
Masimo USD 85.5M 6.4M 2026-03
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Solventum Corp USD 437M 0 2026-03
Stryker USD 1.57B 618M 2026-03
Tandem Diabetes Care USD 2.73M 30.17M 2026-03
Teleflex USD 247.07M 575.88M 2025-12
West Pharmaceutical Services USD 226.2M 7.7M 2026-03
Zimmer Biomet Holdings USD 759M 120.8M 2025-12